GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tonghua Golden-horse Pharmaceutical Industry Co Ltd (SZSE:000766) » Definitions » Accounts Receivable

Tonghua Golden-horse Pharmaceutical Industry Co (SZSE:000766) Accounts Receivable : ¥505 Mil (As of Mar. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Tonghua Golden-horse Pharmaceutical Industry Co Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Tonghua Golden-horse Pharmaceutical Industry Co's accounts receivables for the quarter that ended in Mar. 2024 was ¥505 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Tonghua Golden-horse Pharmaceutical Industry Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 was 156.00.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Tonghua Golden-horse Pharmaceutical Industry Co's Net-Net Working Capital per share for the quarter that ended in Mar. 2024 was ¥-1.51.


Tonghua Golden-horse Pharmaceutical Industry Co Accounts Receivable Historical Data

The historical data trend for Tonghua Golden-horse Pharmaceutical Industry Co's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tonghua Golden-horse Pharmaceutical Industry Co Accounts Receivable Chart

Tonghua Golden-horse Pharmaceutical Industry Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 739.51 434.63 350.61 423.92 496.82

Tonghua Golden-horse Pharmaceutical Industry Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 364.73 436.54 422.07 496.82 505.30

Tonghua Golden-horse Pharmaceutical Industry Co Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Tonghua Golden-horse Pharmaceutical Industry Co Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Tonghua Golden-horse Pharmaceutical Industry Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=505.301/295.573*91
=156.00

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Tonghua Golden-horse Pharmaceutical Industry Co's accounts receivable are only considered to be worth 75% of book value:

Tonghua Golden-horse Pharmaceutical Industry Co's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2024 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(245.626+0.75 * 505.301+0.5 * 385.051-2277.728
-0-0.444)/966.495
=-1.51

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Tonghua Golden-horse Pharmaceutical Industry Co Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Tonghua Golden-horse Pharmaceutical Industry Co's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Tonghua Golden-horse Pharmaceutical Industry Co (SZSE:000766) Business Description

Traded in Other Exchanges
N/A
Address
No. 999, Jinma Road, Erdaojiang District, Tonghua, Jilin, CHN, 134001
Tonghua Golden-horse Pharmaceutical Industry Co Ltd is a pharmaceutical company engaged in the manufacturing and sale of pharmaceutical products. It is a comprehensive pharmaceutical company integrating the production, sales, and research and development of pharmaceuticals. Tonghua's products mainly focus on rheumatism, bone diseases, digestion, tumors, and gynecology and distributing it mainly in the eastern part of China.
Executives
Wei Ying Jie Director
Zan Bao Shi Director
Wu Cheng Yu Directors, executives
Zhang De Ju Supervisors
Li Ju Supervisors
Feng Ran Director

Tonghua Golden-horse Pharmaceutical Industry Co (SZSE:000766) Headlines

No Headlines